A viatical settlement is an investment where you purchase someone's life insurance policy at a discount to its face value. The policyholder, typically someone with a terminal illness, receives immediate cash below what the policy will eventually pay out. You become the new policy owner, take over premium payments, and collect the full death benefit when the insured person passes away. The spread between your purchase price and the payout represents your profit.
How It Works
The process involves three main parties: the policyholder seeking liquidity, a viatical settlement company or broker, and the investor. A terminally ill person with a $1 million life insurance policy might sell it for $400,000-$600,000 depending on life expectancy estimates. You purchase the policy through a licensed broker, assuming all premium obligations. Medical underwriters evaluate the insured's health to estimate life expectancy, which directly affects the discount offered. Once you own the policy, you wait for the death benefit, which becomes your return on investment.
Why It Matters for Investors
Viatical settlements appeal to investors seeking alternative assets uncorrelated with traditional markets. They offer potentially higher returns than bonds or dividend stocks, typically 12-25% annually depending on life expectancy accuracy. However, they carry significant risks: medical advances can extend lifespans beyond projections, increasing your holding period and costs; regulatory changes affect policy ownership; and liquidity is limited since you cannot easily exit the position. These are illiquid, speculative investments best suited for sophisticated investors with high risk tolerance and diversified portfolios.
Example
An investor purchases a $2 million policy from a 65-year-old with stage 4 cancer for $800,000. Medical experts estimate 3-5 years of life expectancy. The investor assumes $15,000 annual premiums. If the insured dies in year 4, the investor receives $2 million, netting $1.2 million profit on their $860,000 total investment (premiums plus purchase price)—roughly 40% total return. If the insured lives 10 years due to new treatments, the investor's returns deteriorate significantly as premium costs accumulate.
Key Takeaways
- Viatical settlements involve purchasing life insurance policies from terminally ill individuals at discounts, with returns tied to death benefit payouts
- Life expectancy estimates are critical—longer lifespans reduce investor returns, making accuracy essential but uncertain
- These are illiquid, high-risk alternative investments requiring substantial capital and emotional tolerance for speculative outcomes
- Regulatory oversight varies by state and country, affecting investment viability and policy transferability